Bio-Gene Technology (ASX:BGT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Bio-Gene Technology (ASX:BGT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notice of Extraordinary General Meeting/Proxy Form
Result of Security Purchase Plan
Application for quotation of securities - BGT
Update - Proposed issue of securities - BGT
Investor Update Webinar
Launch of Security Purchase Plan
Placement Update and Section 708A(5)(e) Notice
Bio-Gene raises $2.775 million via placement with attaching options pending shareholder approval
Application for quotation of securities - BGT
Proposed issue of securities - BGT
Proposed issue of securities - BGT
Proposed issue of securities - BGT
Investor Presentation - Placement
Bio-Gene advances natural insecticides Flavocide and Qcide targeting $44B global markets with key partnerships and US DoD grants
Results of Placement
Bio-Gene raises A$3.21 million via placement and underwritten share purchase plan to fund regulatory and production activities
Trading Halt
BGT to expand Flavocide and Qcide evaluation to Asia
Key insecticide combinations patent allowed in the US
Quarterly Activities/Appendix 4C Cash Flow Report
Bio-Gene advances Flavocide registration, inks Japan Qcide deal, completes 15th harvest
Investor Presentation
Change of Auditor